Verition Fund Management
AIM

Verition Fund Management’s AIM ImmunoTech AIM Stock Holding History

Verition Fund Management’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,622
Closed -$19.8K – 3967
2025
Q1 		$19.8K Sell
1,622
-90
-5% -$1.45K ﹤0.01% 3241
2024
Q4 		$33.9K Buy
1,712
+180
+12% +$4.19K ﹤0.01% 3144
2024
Q3 		$41.3K Hold
1,532
– – ﹤0.01% 3051
2024
Q2 		$57K Sell
1,532
-180
-11% -$7.64K ﹤0.01% 2787
2024
Q1 		$80.5K Buy
1,712
+90
+6% +$3.73K ﹤0.01% 2602
2023
Q4 		$71.3K Buy
1,622
+141
+10% +$6.57K ﹤0.01% 2164
2023
Q3 		$67.3K Buy
1,481
+80
+6% +$4.93K ﹤0.01% 2158
2023
Q2 		$93.8K Sell
1,401
-40
-3% -$1.93K ﹤0.01% 1984
2023
Q1 		$61.9K Sell
1,441
-91
-6% -$4.72K ﹤0.01% 1944
2022
Q4 		$47.7K Hold
1,532
– – ﹤0.01% 1891
2022
Q3 		$89K Hold
1,532
– – ﹤0.01% 2644
2022
Q2 		$119K Hold
1,532
– – ﹤0.01% 2042
2022
Q1 		$162K Sell
1,532
-90
-6% -$7.75K ﹤0.01% 2386
2021
Q4 		$149K Buy
1,622
+136
+9% +$21K ﹤0.01% 2284
2021
Q3 		$300K Buy
1,486
+405
+37% +$81.8K ﹤0.01% 1470
2021
Q2 		$232K Hold
1,081
– – ﹤0.01% 1489
2021
Q1 		$245K Buy
1,081
+480
+80% +$108K ﹤0.01% 1234
2020
Q4 		$107K Buy
601
+201
+50% +$40.2K ﹤0.01% 1017
2020
Q3 		$86K Buy
+400
New +$99.9K ﹤0.01% 998

Other funds holding AIM

Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Verition Fund Management's AIM Position: Q2 2025 in Review

Verition Fund Management sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 1,622 shares — an estimated $19.8K sold.

Verition Fund Management first reported a position in AIM in Q3 2020 and held it in 19 quarters. The position peaked at $300K in Q3 2021. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • Verition Fund Management reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 1,622 AIM ImmunoTech shares in Q2 2025, an estimated $19.8K.
  • Verition Fund Management first reported a position in AIM ImmunoTech in Q3 2020 and held it in 19 quarters.
  • Verition Fund Management's AIM ImmunoTech position peaked at $300K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.